Cathie Wood of Ark Invest first bought shares of Beam Therapeutics (BEAM 4.14%), a biotech focused on precision genetic ...

Across the vast, 3 billion-letter volume that is the human genome, so much can hinge on a single typo. Such was the case for a baby nicknamed KJ. In August 2024, KJ was born a few weeks premature at a ...

The California drugmaker, which has collaborations in place with Biogen, Sanofi and Eli Lilly, could be the 14th biotech to go public in 2026.

Researchers from the Department of Biomedical Engineering at UNIST and the Center for Genomic Integrity at the Institute for Basic Science (IBS) have announced an advance in cancer gene therapy. Their ...

Multisystemic smooth muscle dysfunction syndrome (MSMDS) is a rare condition associated with stroke, aortic dissection (tearing) and death in childhood. Currently ...

Amy Scott, host of the podcast "How We Survive," reports on a company that's working on de-extinction innovation to try and ...

Researchers in Mexico are turning their focus towards a revolutionary technique to enhance crop resilience. According to News Arena India, the International Maize and Wheat Improvement Center, also ...

The stigmatized idea could get a massive boost from “tech bros”—and some scientists are cheering them on. Brian Armstrong, the billionaire CEO of the cryptocurrency exchange Coinbase, says he’s ready ...

A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects for millions living with complex inherited diseases, such as cystic ...

New research shows it’s possible to edit the DNA of human embryos with more precision. But scientists warn it’s still not ...

Researchers at King Abdullah University of Science and Technology (KAUST) have developed a new way to add large pieces of ...